Evaluation of efficacy of intranasal oxytocin spray on children with autistic disorder
Not Applicable
- Conditions
- Autistic disorder
- Registration Number
- JPRN-UMIN000003812
- Lead Sponsor
- Osaka University United Graduate School of Child Development
- Brief Summary
Tachibana M, Kagitani-Shimono K, Mohri I, Yamamoto T, Sanefuji W, Nakamura A, Oishi M, Kimura T, Onaka T, Ozono K, Taniike M. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. J Child Adolesc Psychopharmacol. 2013 Mar;23(2):123-7.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Boys without development of secondary sexual characteristics 2. Comorbid heart disorders 3. In cases where the attending doctors judged the participation to the study as inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Behavioral Evaluation of children by child behavior checklist(CBCL), autism diagnostic observation schedule(ADOS), childhood autism rating scale(CARS) will be performed before and 6 and 12 months after the initiation of therapy.
- Secondary Outcome Measures
Name Time Method